Corcept Therapeutics Announces Fourth Quarter Results and Full Year Revenue and Corporate Update

[at noodls] – MENLO PARK, Calif. – February 12, 2013 Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment … more

View todays social media effects on CORT

View the latest stocks trending across Twitter. Click to view dashboard

See who Corcept is hiring next, click here to view